Multi-center trial now recruiting worldwide

Status
Not open for further replies.

lgelb

Moderator
Forum Supporter
Joined
Nov 5, 2009
Messages
14,212
Reason
Lost a loved one
Diagnosis
00/0000
Country
US
State
WA
City
Seattle
The aim of this trial is to test a heart failure drug (levosimendan) already on the market to confirm an earlier study suggesting respiratory impairment could be delayed.

It's an oral capsule, the trial is placebo-controlled, and you cannot be on BiPAP.
 
Thanks Laurie. I don’t remember seeing a trial before that has an exclusion for a high svc. It is more usual tosee svc greater than x than a range.
 
Yup, they need to show benefit via SVC, so has to be early enough in progression to show a benefit, but not so good that there is no progression to slow down.
 
Status
Not open for further replies.
Back
Top